2014 Annual Meeting | 3HC.012 - Sleep Principles Applied to Neurological Disease

Date Monday 04/28/14

Time 01:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Marcel Hungs, MD, PhD, F�鶹��ýӳ��

Topic(s)

Learning Objectives Participants should be able to: understand the importance of sleep to brain function; be able to identify patients with neurologic disorders who have sleep issues; and apply sleep and neurologic principles to sleep complaints.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Tracks Subspecialty in Focus

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic

Event Timeline
01:00 PM - 01:35 PM		Not Again - Neurologic Approach to Insomnia Charlene Gamaldo, MD, F�鶹��ýӳ��
01:35 PM - 02:10 PM		Orexin/Hypocretin Dysfunction and Narcolepsy: Stuck in the Revolving Door Between Wake and Sleep Marcel Hungs, MD, PhD, F�鶹��ýӳ��
02:10 PM - 02:50 PM		Sleep-related Respiratory Disorders in Neurologic Diseases: An Update Clete A. Kushida, MD, PhD
02:50 PM - 03:05 PM		Break
03:05 PM - 03:45 PM		A Marker and a Treatment Opportunity: Sleep in Neurodegenerative Disorders Ronald Postuma, MD
03:45 PM - 04:25 PM		Iron, Opioids, and Dopamine: What Therapies Tell Us About RLS David B. Rye, MD, PhD
04:25 PM - 05:00 PM		Baby-Baby: Update in Pediatric Sleep Phillip L. Pearl, MD, F�鶹��ýӳ��

Faculty Disclosures
Marcel Hungs, MD, PhD, F�鶹��ýӳ��	No disclosure on file
Charlene Gamaldo, MD, F�鶹��ýӳ��	Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for johns hopkins. Dr. Gamaldo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Gamaldo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apnimed. The institution of Dr. Gamaldo has received research support from NIH/NIMH/NIDA/NINDS. Dr. Gamaldo has received publishing royalties from a publication relating to health care.
Clete A. Kushida, MD, PhD	Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avadel. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for XW Pharma, Inc.. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zephyr Sleep Technologies. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vivos. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebra. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co., Inc.. Dr. Kushida has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for State of Arizona. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Browne George Ross, LLP. The institution of Dr. Kushida has received research support from AmCAD, Philips-Respironics, Asate, Syneos Health, Inspire. Dr. Kushida has received publishing royalties from a publication relating to health care.
Phillip L. Pearl, MD, F�鶹��ýӳ��	Dr. Pearl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care.
Ronald Postuma, MD	Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.
David B. Rye, MD, PhD	No disclosure on file